Cannovum Cannabis AG Logo

Cannovum Cannabis AG

Licensed importer, wholesaler, and manufacturer of medical cannabis products.

27N0 | DU

Overview

Corporate Details

ISIN(s):
DE000A30VHF2 (+2 more)
LEI:
894500IT61F9P85YMM31
Country:
Germany
Address:
Stresemannstraße 23, 10963 Berlin

Description

Cannovum Cannabis AG is a pharmaceutical company that operates as a licensed importer, wholesaler, and manufacturer of high-quality medical cannabis products. The company's primary focus is on supplying the medical market and providing patients with therapeutic options. In response to evolving regulations, Cannovum is also strategically positioning itself for the legalized recreational cannabis market. This includes initiatives aimed at public education and brand awareness, alongside developing a product portfolio for the adult-use consumer segment. The company is also engaged in expanding its operations into other European markets.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Select rows to enable
Date Filing Language Type / Size Actions
2023-07-12 07:35
Cannovum Cannabis AG: Cooperation with Osnabruck University of Applied Sciences
English HTML 9.5 KB
2023-06-30 08:19
Cannovum Cannabis AG : Cultivation alliance for recreational cannabis continues…
English HTML 8.9 KB
2023-06-28 18:05
Cannovum Cannabis AG :Cannovum Cannabis AG: Planned capital measures with rever…
English HTML 6.8 KB
2023-06-19 15:04
Cannovum Cannabis AG : Cannovum Cannabis AG: Full focus on the legalization of …
English HTML 6.8 KB
2023-06-02 14:03
Cannovum Cannabis AG: Annual financial statements 2022 and issuance of further …
English HTML 8.4 KB
2023-05-12 09:28
Cannovum Cannabis AG signs agreement together with to establish cultivation all…
English HTML 8.2 KB
2023-04-25 11:30
Cannovum AG Focus on Recreational Cannabis and Change of Name to Cannovum Canna…
English HTML 7.6 KB
2023-04-19 09:44
Cannovum AG develops cultivation kits for Cannabis Social Clubs
English HTML 8.0 KB
2023-02-02 08:25
Cannovum AG: Cannovum AG establishes cultivation alliance for recreational cann…
English HTML 9.6 KB
2022-12-15 09:00
Cannovum AG share enters Xetra trading
English HTML 6.5 KB
2022-11-28 08:30
Cannovum AG shares move Dec. 1st 2022 to primary market of Dusseldorf Stock Exc…
English HTML 6.1 KB
2022-11-25 13:07
Cannovum AG expands management board
English HTML 6.7 KB
2022-11-17 08:59
Cannovum AG: Ausgabe von Wandelschuldverschreibungen im Volumen von bis zu EUR …
German HTML 6.8 KB
2022-10-19 11:40
Cannovum AG welcomes concrete steps towards legalization of cannabis
English HTML 6.3 KB
2022-10-10 09:48
Cannovum AG: Joint research project with Macromedia University on the future of…
English HTML 8.0 KB

Automate Your Workflow. Get a real-time feed of all Cannovum Cannabis AG filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Cannovum Cannabis AG

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Cannovum Cannabis AG via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Access Bio, Inc. Logo
Develops and manufactures in vitro diagnostic solutions for infectious diseases.
United States of America
950130
ACHIEVE LIFE SCIENCES, INC. Logo
A late-stage pharmaceutical company developing a treatment for nicotine dependence.
United States of America
ACHV
AC Immune SA Logo
Biopharmaceutical firm developing precision medicine for neurodegenerative diseases.
United States of America
ACIU
Aclaris Therapeutics, Inc. Logo
Clinical-stage biopharmaceutical company developing drugs for immuno-inflammatory diseases.
United States of America
ACRS
Acrivon Therapeutics, Inc. Logo
Clinical-stage biopharma using proteomics to develop precision oncology therapies.
United States of America
ACRV
Acticor Biotech Logo
Develops treatments for thrombotic diseases, focusing on acute ischemic stroke.
France
ALACT
Actinium Pharmaceuticals, Inc. Logo
Clinical-stage company developing targeted radiotherapies for difficult-to-treat cancers.
United States of America
ATNM
ACTUATE THERAPEUTICS, INC. Logo
Clinical-stage biopharma developing therapies for cancers with high unmet needs.
United States of America
ACTU
AcuCort AB Logo
Develops user-friendly drug formulations for severe and acute allergic reactions.
Sweden
ACUC
Acumen Pharmaceuticals, Inc. Logo
Clinical-stage biopharma developing targeted therapies for Alzheimer's disease.
United States of America
ABOS

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.